{"entity":{"type":"insider","cik":"0001658544","url":"/insider/0001658544","json_url":"/insider/0001658544.json","name":"Kelly Paul Edward","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":16,"first":"2015-12-16","last":"2025-11-06","span_basis":"filed_date"},"name_variants":[{"name":"Kelly Paul Edward","source":"filing","n_filings":16,"first_seen":"2015-12-16","last_seen":"2025-11-06"}],"transactions":[{"id":4674096,"accession":"0001213900-25-106835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-106835","line_url":"/filing/0001213900-25-106835#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90000.0,"shares_display":"90,000","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":198000.0,"total_display":"198,000.00","total_whole":"198,000","shares_owned_after":502295.0,"shares_owned_after_display":"502,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-06","scope":"insider"},{"id":5109025,"accession":"0001213900-25-046088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-046088","line_url":"/filing/0001213900-25-046088#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":0.4303,"price_display":"0.43","price_state":"stated","total_value":86060.0,"total_display":"86,060.00","total_whole":"86,060","shares_owned_after":412295.0,"shares_owned_after_display":"412,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":3132603,"accession":"0001213900-24-077791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-077791","line_url":"/filing/0001213900-24-077791#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.59,"price_display":"2.59","price_state":"stated","total_value":64750.0,"total_display":"64,750.00","total_whole":"64,750","shares_owned_after":212295.0,"shares_owned_after_display":"212,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-11","scope":"insider"},{"id":6361084,"accession":"0001213900-22-018223","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-22-018223","line_url":"/filing/0001213900-22-018223#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0395,"price_display":"30.04","price_state":"stated","total_value":300395.0,"total_display":"300,395.00","total_whole":"300,395","shares_owned_after":187295.0,"shares_owned_after_display":"187,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider"},{"id":4189805,"accession":"0001213900-21-014917","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-014917","line_url":"/filing/0001213900-21-014917","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":35.710178,"price_display":"35.71","price_state":"stated","total_value":178550.89,"total_display":"178,550.89","total_whole":"178,551","shares_owned_after":168907.0,"shares_owned_after_display":"168,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-09","filed_date":"2021-03-11","scope":"insider","n_lines":2},{"id":5016595,"accession":"0001213900-21-012171","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-21-012171","line_url":"/filing/0001213900-21-012171","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":34.18659916,"price_display":"34.19","price_state":"stated","total_value":170932.9958,"total_display":"170,933.00","total_whole":"170,933","shares_owned_after":167403.0,"shares_owned_after_display":"167,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-24","filed_date":"2021-02-26","scope":"insider","n_lines":3},{"id":4149240,"accession":"0001213900-21-008203","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-008203","line_url":"/filing/0001213900-21-008203#line-3","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2069.0,"shares_display":"2,069","price_per_share":35.285,"price_display":"35.28","price_state":"stated","total_value":73004.665,"total_display":"73,004.66","total_whole":"73,005","shares_owned_after":162295.0,"shares_owned_after_display":"162,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider"},{"id":4149239,"accession":"0001213900-21-008203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-008203","line_url":"/filing/0001213900-21-008203#line-2","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":35.0399,"price_display":"35.04","price_state":"stated","total_value":52559.85,"total_display":"52,559.85","total_whole":"52,560","shares_owned_after":164364.0,"shares_owned_after_display":"164,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5262476,"accession":"0001213900-21-006570","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-21-006570","line_url":"/filing/0001213900-21-006570#line-4","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2315.0,"shares_display":"2,315","price_per_share":35.04,"price_display":"35.04","price_state":"stated","total_value":81117.6,"total_display":"81,117.60","total_whole":"81,118","shares_owned_after":162295.0,"shares_owned_after_display":"162,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":5262472,"accession":"0001213900-21-006570","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-006570","line_url":"/filing/0001213900-21-006570#line-3","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31.0,"shares_display":"31","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":1085.0,"total_display":"1,085.00","total_whole":"1,085","shares_owned_after":164610.0,"shares_owned_after_display":"164,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":5349102,"accession":"0001213900-21-005443","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-21-005443","line_url":"/filing/0001213900-21-005443","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.464576,"price_display":"32.46","price_state":"stated","total_value":162322.88,"total_display":"162,322.88","total_whole":"162,323","shares_owned_after":147463.0,"shares_owned_after_display":"147,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-27","filed_date":"2021-01-29","scope":"insider","n_lines":3},{"id":4106631,"accession":"0001213900-21-004482","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-21-004482","line_url":"/filing/0001213900-21-004482#line-5","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":685.0,"shares_display":"685","price_per_share":35.16,"price_display":"35.16","price_state":"stated","total_value":24084.6,"total_display":"24,084.60","total_whole":"24,085","shares_owned_after":147295.0,"shares_owned_after_display":"147,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-26","scope":"insider"},{"id":4106624,"accession":"0001213900-21-004482","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-21-004482","line_url":"/filing/0001213900-21-004482#line-4","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":35.27,"price_display":"35.27","price_state":"stated","total_value":45851.0,"total_display":"45,851.00","total_whole":"45,851","shares_owned_after":147980.0,"shares_owned_after_display":"147,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-26","scope":"insider"},{"id":9272825,"accession":"0001213900-21-004512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-004512","line_url":"/filing/0001213900-21-004512#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":35.43,"price_display":"35.43","price_state":"stated","total_value":63774.0,"total_display":"63,774.00","total_whole":"63,774","shares_owned_after":149580.0,"shares_owned_after_display":"149,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-22","filed_date":"2021-01-27","scope":"insider"},{"id":4106621,"accession":"0001213900-21-004482","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-004482","line_url":"/filing/0001213900-21-004482","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":3042.0257142857145,"price_display":"3,042.03","price_state":"stated","total_value":6388254.0,"total_display":"6,388,254.00","total_whole":"6,388,254","shares_owned_after":149580.0,"shares_owned_after_display":"149,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-22","filed_date":"2021-01-26","scope":"insider","n_lines":2},{"id":7886163,"accession":"0001213900-19-020706","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001213900-19-020706","line_url":"/filing/0001213900-19-020706","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":19.137,"price_display":"19.14","price_state":"stated","total_value":95685.0,"total_display":"95,685.00","total_whole":"95,685","shares_owned_after":127121.0,"shares_owned_after_display":"127,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-18","filed_date":"2019-10-21","scope":"insider","n_lines":7},{"id":8169567,"accession":"0001213900-19-008815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-008815","line_url":"/filing/0001213900-19-008815#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":488483.0,"shares_owned_after_display":"488,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-15","scope":"insider"},{"id":6297199,"accession":"0001213900-18-017210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-017210","line_url":"/filing/0001213900-18-017210#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.213,"price_display":"1.21","price_state":"stated","total_value":6065.0,"total_display":"6,065.00","total_whole":"6,065","shares_owned_after":388483.0,"shares_owned_after_display":"388,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-11","scope":"insider"},{"id":6338714,"accession":"0001213900-18-014143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-014143","line_url":"/filing/0001213900-18-014143#line-1","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":135000.0,"total_display":"135,000.00","total_whole":"135,000","shares_owned_after":160000.0,"shares_owned_after_display":"160,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-12","filed_date":"2018-10-19","scope":"insider"},{"id":8786777,"accession":"0001213900-15-009522","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-15-009522","line_url":"/filing/0001213900-15-009522","is_derivative":false,"issuer_cik":"0001553643","issuer_name":"RELMADA THERAPEUTICS, INC.","issuer_ticker":"RLMD","issuer_name_source":null,"issuer_url":"/issuer/0001553643","owner_cik":"0001658544","owner_name":"Kelly Paul Edward","owner_display_name":"Kelly Paul Edward","owner_url":"/insider/0001658544","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.9055,"price_display":"2.91","price_state":"stated","total_value":29055.0,"total_display":"29,055.00","total_whole":"29,055","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2015-12-16","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001553643","name":"RELMADA THERAPEUTICS, INC.","url":"/issuer/0001553643","role":"Director, Officer (Chief Operating Officer)","n_filings":16,"first_seen":"2015-12-16","last_seen":"2025-11-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001658544","retrieved_at":"2026-08-26T09:13:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}